Skip to content

ClearPoint Neuro CLPT Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
IAR
Integra LifeSciencesIART
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's deferred tax assets and other non-current assets?
ClearPoint Neuro (CLPT) reported deferred tax assets and other non-current assets of $1.65M in Q1 2026.
How has ClearPoint Neuro's deferred tax assets and other non-current assets changed year-over-year?
ClearPoint Neuro's deferred tax assets and other non-current assets increased by 1012.2% year-over-year, from $148K to $1.65M.
What is the long-term trend for ClearPoint Neuro's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), ClearPoint Neuro's deferred tax assets and other non-current assets has grown at a 96.6% compound annual growth rate (CAGR), from $58K to $1.7M.